Patents by Inventor Sandra Fabienne NOTONIER

Sandra Fabienne NOTONIER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Conversion of S-lignin compounds to useful intermediates
    Patent number: 11807873
    Abstract: The present disclosure relates to a genetically modified microbial cell that includes a first genetic modification resulting in the expression of an exogenous vanillate demethylase, such that the microbial cell is capable of metabolizing an S-lignin decomposition product and producing 2-pyrone-4,6-dicarboxylate (PDC).
    Type: Grant
    Filed: October 19, 2021
    Date of Patent: November 7, 2023
    Assignee: Alliance for Sustainable Energy, LLC
    Inventors: Christopher W. Johnson, Allison Jean Zimont Werner, Gregg Tyler Beckham, Sandra Fabienne Notonier
  • CONVERSION OF S-LIGNIN COMPOUNDS TO USEFUL INTERMEDIATES
    Publication number: 20220119849
    Abstract: The present disclosure relates to a genetically modified microbial cell that includes a first genetic modification resulting in the expression of an exogenous vanillate demethylase, such that the microbial cell is capable of metabolizing an S-lignin decomposition product and producing 2-pyrone-4,6-dicarboxylate (PDC).
    Type: Application
    Filed: October 19, 2021
    Publication date: April 21, 2022
    Inventors: Christopher W. JOHNSON, Allison Jean ZIMONT WERNER, Gregg Tyler BECKHAM, Sandra Fabienne NOTONIER
  • Conversion of S-lignin compounds to useful intermediates
    Patent number: 11136601
    Abstract: The present disclosure relates to a genetically modified microbial cell that includes a genetic modification resulting in the expression of a vanillate demethylase, where the microbial cell is capable of metabolizing at least one S-lignin decomposition molecule including at least one of syringate and/or 3-O-methyl gallate, and the genetically modified microbial cell is capable of producing gallate. In some embodiments of the present disclosure, the vanillate demethylase may include VanAB.
    Type: Grant
    Filed: August 2, 2019
    Date of Patent: October 5, 2021
    Assignee: Alliance for Sustainable Energy, LLC
    Inventors: Gregg Tyler Beckham, Christopher W. Johnson, Sandra Fabienne Notonier
  • CONVERSION OF S-LIGNIN COMPOUNDS TO USEFUL INTERMEDIATES
    Publication number: 20200071731
    Abstract: The present disclosure relates to a genetically modified microbial cell that includes a genetic modification resulting in the expression of a vanillate demethylase, where the microbial cell is capable of metabolizing at least one S-lignin decomposition molecule including at least one of syringate and/or 3-O-methyl gallate, and the genetically modified microbial cell is capable of producing gallate. In some embodiments of the present disclosure, the vanillate demethylase may include VanAB.
    Type: Application
    Filed: August 2, 2019
    Publication date: March 5, 2020
    Inventors: Gregg Tyler BECKHAM, Christopher W. JOHNSON, Sandra Fabienne NOTONIER